Trump's Vaccine and Tylenol Claims Trigger Medical Debate

President Donald Trump has sparked controversy by claiming a link between autism and both childhood vaccines and the pain reliever Tylenol, particularly when used by pregnant women and young children. He criticized the current vaccine schedule, suggesting that children receive excessive dosages comparable to those given to horses, and proposed spreading out vaccinations over several years. These assertions, often made alongside vaccine skeptic Robert F. Kennedy Jr., contradict established scientific consensus, which maintains that vaccines are safe and critical for public health. Experts and medical authorities, including the FDA and autism researchers, have dismissed Trump's claims as inaccurate and unsupported by evidence. Trump's remarks have also caused a temporary dip in the stock value of Kenvue, Tylenol's manufacturer, and raised concerns about the potential spread of misinformation. The president's upcoming announcement on autism, expected to feature Kennedy Jr. and Dr. Mehmet Oz, aims to address autism causes and treatments but has been met with skepticism from the medical community.